Author:
Montillo M,Tedeschi A,Rossi V,Cairoli R,Pungolino E,Intropido L,Cafro A M,D'Avanzo G,Farioli R,Brando B,Scarpati B,Veronese S,Morra E
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference33 articles.
1. Gratwhol A, Passweg J, Baldomero H, Hermans J . Blood and marrow transplantation activity in Europe 1997. European Group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 1999; 24: 231–245.
2. Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228–2235.
3. Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H . The CAMPATH 1-H antigen (CDw52). Tissue Antigens 1990; 35: 118–127.
4. Treumann A, Lifely MR, Schneider P, Ferguson MA . Primary structure of CD52. J Biol Chem 1995; 270: 6088–6099.
5. Montillo M, Cafro AM, Tedeschi A, Brando B, Oreste PL, Veronese S et al. Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine. Haematologica 2002; 87: 695–700.